WO2000023061A3 - Irrigation solution and method for inhibition of pain and inflammation - Google Patents
Irrigation solution and method for inhibition of pain and inflammation Download PDFInfo
- Publication number
- WO2000023061A3 WO2000023061A3 PCT/US1999/024557 US9924557W WO0023061A3 WO 2000023061 A3 WO2000023061 A3 WO 2000023061A3 US 9924557 W US9924557 W US 9924557W WO 0023061 A3 WO0023061 A3 WO 0023061A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antagonist
- pain
- solution
- inflammation
- inhibitor
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 4
- 230000004054 inflammatory process Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 230000005764 inhibitory process Effects 0.000 title abstract 2
- 229940113601 irrigation solution Drugs 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 3
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229940111134 coxibs Drugs 0.000 abstract 2
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 abstract 1
- 102000016924 KATP Channels Human genes 0.000 abstract 1
- 108010053914 KATP Channels Proteins 0.000 abstract 1
- 102000000033 Purinergic Receptors Human genes 0.000 abstract 1
- 108010080192 Purinergic Receptors Proteins 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000002262 irrigation Effects 0.000 abstract 1
- 238000003973 irrigation Methods 0.000 abstract 1
- 239000002742 neurokinin 1 receptor antagonist Substances 0.000 abstract 1
- 239000002746 neurokinin 2 receptor antagonist Substances 0.000 abstract 1
- 239000003402 opiate agonist Substances 0.000 abstract 1
- 239000004036 potassium channel stimulating agent Substances 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 abstract 1
- 239000000952 serotonin receptor agonist Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU12148/00A AU1214800A (en) | 1998-10-21 | 1999-10-20 | Irrigation solution and method for inhibition of pain and inflammation |
US09/839,633 US20020028798A1 (en) | 1995-12-12 | 2001-04-20 | Irrigation solution and method for inhibition of pain and inflammation |
US09/839,633 US7091181B2 (en) | 1994-12-12 | 2001-04-20 | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
US11/410,406 US20060205657A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,407 US20060205658A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/409,919 US20060229588A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10516698P | 1998-10-21 | 1998-10-21 | |
US60/105,166 | 1998-10-21 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/072,913 Continuation-In-Part US6261279B1 (en) | 1994-12-12 | 1998-05-04 | Surgical irrigation solution and method for inhibition of pain and inflammation |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024558 Continuation-In-Part WO2000023062A2 (en) | 1994-12-12 | 1999-10-20 | Irrigation solution and method for inhibition of pain and inflammation |
US09/839,633 Continuation-In-Part US20020028798A1 (en) | 1994-12-12 | 2001-04-20 | Irrigation solution and method for inhibition of pain and inflammation |
US11/409,919 Continuation-In-Part US20060229588A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,406 Continuation-In-Part US20060205657A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,407 Continuation-In-Part US20060205658A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000023061A2 WO2000023061A2 (en) | 2000-04-27 |
WO2000023061A3 true WO2000023061A3 (en) | 2000-11-16 |
Family
ID=22304411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024557 WO2000023061A2 (en) | 1994-12-12 | 1999-10-20 | Irrigation solution and method for inhibition of pain and inflammation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1214800A (en) |
WO (1) | WO2000023061A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004521856A (en) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor |
CN101327325A (en) | 2002-07-30 | 2008-12-24 | 奥默罗斯公司 | Ophthalmologic irrigation solutions and method |
CA2676357A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI809304B (en) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5373022A (en) * | 1991-03-04 | 1994-12-13 | The Warner-Lambert Company | Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
US5820583A (en) * | 1995-12-12 | 1998-10-13 | Omeros Medical Systems, Inc. | Surgical irrigation solution and method for inhibition of pain and inflammation |
-
1999
- 1999-10-20 AU AU12148/00A patent/AU1214800A/en not_active Abandoned
- 1999-10-20 WO PCT/US1999/024557 patent/WO2000023061A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5373022A (en) * | 1991-03-04 | 1994-12-13 | The Warner-Lambert Company | Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
US5820583A (en) * | 1995-12-12 | 1998-10-13 | Omeros Medical Systems, Inc. | Surgical irrigation solution and method for inhibition of pain and inflammation |
Non-Patent Citations (10)
Title |
---|
BURITOVA JAROSLAVA; CHAPMAN VICTORIA; HONORE PRISCA; BESSON JEAN-MARIE: "Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the rat.", BRAIN RESEARCH, vol. 715, no. 1-2, 1996, pages 217 - 220, XP000905607 * |
ENGELHARDT G: "Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.", BRITISH JOURNAL OF RHEUMATOLOGY, vol. 35, no. suppl. 1, 1996, pages 4 - 12, XP000905630 * |
HAY CATRIONA; DE BELLEROCHE JACQUELINE: "Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord.", NEUROREPORT, vol. 8, no. 5, 1997, pages 1249 - 1251, XP000905625 * |
JOSHI G.P.: "Postoperative pain management.", INTERNATIONAL ANESTHESIOLOGY CLINICS, (1994) 32/3 (113-126)., XP000905593 * |
MEHLISCH D R; HUBBARD R C; ISAKSON P; KARIM A; WEAVER M; MILLS S: "Analgesic efficacy and plasma levels of a highly selective inhibitor of COX-2 (SC-58635;SC) in patients with post-surgical dental pain.", CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 61, no. 2, 1997, pages 195, XP000905616 * |
OSIPOVA N A: "[Antinociceptive components of general anesthesia and postoperative analgesia]. Antinotsitseptivnye komponenty obschchei anestezii i posleoperatsionnoi analgezii.", ANESTEZIOLOGIIA I REANIMATOLOGIIA, (1998 SEP-OCT) (5) 11-5. REF: 21, XP000905655 * |
REYNOLDS J.: "Martindale - The Extra Pharmacopoeia Edition 31", 1996, ROYAL PHARMACEUTICAL SOCIETY, LONDON GB, XP002137139, 224540 * |
SCHWEIZER A; BROM R; WIESENBERG-BOETTCHER I: "INHIBITION OF INTERLEUKIN-1 IL-1 ENHANCED PAIN REFLEXES IN THE RABBIT BY CGP-28238", AGENTS AND ACTIONS, vol. 32, no. 1-2, 1991, pages 67 - 69, XP000905639 * |
SEIBERT KAREN; ZHANG YAN; LEAHY KATHLEEN; HAUSER SCOTT; MASFERRER JAIME; PERKINS WILLIAM; LEE LEN; ISAKSON PETER: "Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 91, no. 25, 1994, pages 12013 - 12017, XP000604765 * |
SOUTER A J ET AL: "CONTROVERSIES IN THE PERIOPERATIVE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS", ANESTHESIA AND ANALGESIA, (DEC 1994) VOL. 79, NO. 6, PP. 1178-1190. ISSN: 0003-2999., UNIV TEXAS, SW MED CTR, DEPT ANESTHESIOL & PAIN MANAGEMENT, 5323 HARRY HINES BLVD, DALLAS, TX, 75235 (Reprint);UNIV TEXAS, SW MED CTR, DEPT ANESTHESIOL & PAIN MANAGEMENT, DALLAS, TX, 75235, XP000905591 * |
Also Published As
Publication number | Publication date |
---|---|
AU1214800A (en) | 2000-05-08 |
WO2000023061A2 (en) | 2000-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001007067A3 (en) | Solutions and methods for inhibition of pain, inflammation and cartilage degradation | |
AU6397496A (en) | Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis | |
WO2000023062A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
MX9703988A (en) | Irrigation solution and method for inhibition of pain, inflammation and spasm. | |
WO2005044194A3 (en) | TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR | |
CA2387247A1 (en) | Use of neutralizing agents to growth factors for reducing wound scarring | |
PT646012E (en) | CURE OF WOUNDS AND TREATMENT OF FIBROTIC PERTURBACTIONS BY TGFBETA-3 | |
NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
WO2000025745A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
BR0113749A (en) | Methods to inhibit decrease in transdermal drug flow by inhibiting pathway closure | |
EP1230919A3 (en) | Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage | |
GEP20063828B (en) | Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents | |
AP1780A (en) | Use of cox-2 inhibitors for preventing immunodeficiency. | |
WO2000023061A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
CA2179015A1 (en) | Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase | |
HK1048259A1 (en) | Irrigation solution and method for inhibition of pain and inflammation. | |
RU94044356A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for thrombodulin expression increase to inhibit thrombotic disorder, for protein c activation | |
EP1563838A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
WO2002085292A3 (en) | Improved method for treating aberrant fibrotic tisue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof | |
WO2004069029A3 (en) | Prevention of surgical adhesions using selective cox-2 inhibitors | |
EP1051993A3 (en) | 5HT1 receptor agonists and either a COX-2 inhibitor or NSAID for the treatment of migraine | |
BR0014751A (en) | Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound | |
WO2000032155A3 (en) | Skin care compositions containing zinc salts and retinoids | |
WO2003093415A3 (en) | Methods useful in treatment and prevention of hiv infection | |
CA2251353A1 (en) | Transdermal delivery device for azapirone compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 12148 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11410407 Country of ref document: US Ref document number: 11409919 Country of ref document: US Ref document number: 11410406 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11410407 Country of ref document: US Ref document number: 11410406 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11409919 Country of ref document: US |